Absence of cardiovascular disease risk factors in restless legs syndrome.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 21718253)

Published in Acta Neurol Scand on July 01, 2011

Authors

F I I Cosentino1, D Aricò, B Lanuzza, A Raggi, G Sciortino, M Tripodi, R Bella, M Zucconi, R Ferri

Author Affiliations

1: Department of Neurology I.C., Oasi Institute for Research on Mental Retardation and Brain Aging, Troina, Italy.

Articles by these authors

Environmental risk factors for REM sleep behavior disorder: a multicenter case-control study. Neurology (2012) 2.54

CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsy. Neurology (2008) 2.37

A single question for the rapid screening of restless legs syndrome in the neurological clinical practice. Eur J Neurol (2007) 2.34

APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31

Autosomal dominant nocturnal frontal lobe epilepsy: electroclinical picture. Epilepsia (1996) 2.18

Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia (2000) 1.80

Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med (1986) 1.73

Absence of response to early transcranial magnetic stimulation in ischemic stroke patients: prognostic value for hand motor recovery. Stroke (1999) 1.73

Cognitive dysfunction in patients with obstructive sleep apnea (OSA): partial reversibility after continuous positive airway pressure (CPAP). Brain Res Bull (2003) 1.62

Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytes. EMBO J (1997) 1.60

Lumbar extradural hemangiomas: report of three cases. AJNR Am J Neuroradiol (1999) 1.55

Longitudinal red streaks on the big toenails in a patient with pseudobulbar syndrome. J Eur Acad Dermatol Venereol (2001) 1.54

Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver. EMBO J (1998) 1.50

Snoring and nocturnal oxygen desaturations in an Italian middle-aged male population. Epidemiologic study with an ambulatory device. Chest (1994) 1.50

Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy. Circulation (2001) 1.46

Prevalence of every night snoring and obstructive sleep apnoeas among 30-69-year-old men in Bologna, Italy. Acta Neurol Scand (1989) 1.45

Cutis verticis gyrata and chromosomal fragile sites. Am J Med Genet (1991) 1.43

Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia (1999) 1.42

Does a peculiar EEG pattern exist also for FRAXE mental retardation? Clin Neurophysiol (2000) 1.41

Clonazepam and vibration in restless legs syndrome. Acta Neurol Scand (1984) 1.38

DNA sequences complementary to human 7 SK RNA show structural similarities to the short mobile elements of the mammalian genome. J Mol Biol (1984) 1.37

Heart rate variability during sleep in snorers with and without obstructive sleep apnea. Chest (1992) 1.37

A sequence upstream from the coding region is required for the transcription of the 7SK RNA genes. Nucleic Acids Res (1986) 1.33

Sleep-related breathing impairment in myotonic dystrophy. J Neurol (1987) 1.31

Inhibition of MMH (Met murine hepatocyte) cell differentiation by TGF(beta) is abrogated by pre-treatment with the heritable differentiation effector FGF1. J Cell Sci (2000) 1.30

p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene (1998) 1.27

Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD): does the idiopathic form of RBD really exist? Neurology (2004) 1.22

Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry (2012) 1.20

Sleep structure in essential hypertensive patients: differences between dippers and non-dippers. Blood Press (1995) 1.20

Autosomal dominant nocturnal frontal lobe epilepsy. A video-polysomnographic and genetic appraisal of 40 patients and delineation of the epileptic syndrome. Brain (1998) 1.19

Muscle AMP aminohydrolase. 3. A comparative study on the regulatory properties of skeletal muscle enzyme from various species. Biochim Biophys Acta (1970) 1.17

Expression of human alpha 1-acid glycoprotein genes in cultured cells and in transgenic mice. Genes Dev (1988) 1.15

Insomnia: an epidemiological survey. Clin Neuropharmacol (1985) 1.12

Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings. J Neurol Sci (1994) 1.12

Zolpidem-polysomnographic study of the effect of a new hypnotic drug in sleep apnea syndrome. Pharmacol Biochem Behav (1988) 1.10

Sleep in subjects with autistic disorder: a neurophysiological and psychological study. Brain Dev (2000) 1.08

Early detection of skin and muscular involvement in Lafora disease. J Neurol (1991) 1.07

Muscle AMP aminohydrolase. I. Some regulatory properties of rat skeletal muscle enzyme. Biochim Biophys Acta (1968) 1.07

Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer. Oncogene (2011) 1.06

Disability in chronic daily headache: state of the art and future directions. Neurol Sci (2011) 1.06

Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group. Sleep Med (2013) 1.06

Transcranial magnetic stimulation after pure motor stroke. Clin Neurophysiol (2002) 1.04

Alterations of nasal mucociliary transport in patients with hypertrophy of the inferior turbinates, deviations of the nasal septum and chronic sinusitis. Eur Arch Otorhinolaryngol (1999) 1.04

Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies. Gene Ther (2003) 1.03

Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosis. Neurology (1994) 1.03

Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome. Neurology (2011) 1.02

Evidence of peripheral axonal neuropathy in primary restless legs syndrome. Mov Disord (1995) 1.02

Relationships between headache and sleep in a non-clinical population of children and adolescents. Sleep Med (2007) 1.01

Cytokine-regulated expression of collagenase-2 (MMP-8) is involved in the progression of ovarian cancer. Eur J Cancer (2003) 1.01

Staging of heavy snorers' disease. A proposal. Bull Eur Physiopathol Respir (1984) 1.01

Burden of migraine: international perspectives. Neurol Sci (2013) 1.00

Identification of a bipotential precursor cell in hepatic cell lines derived from transgenic mice expressing cyto-Met in the liver. J Cell Biol (1998) 1.00

A further family with epilepsy, dementia and yellow teeth: the Kohlschütter syndrome. Brain Dev (1995) 0.99

Recognition efficiency of the hepatitis B virus polyadenylation signals is tissue specific in transgenic mice. J Virol (1992) 0.99

L-acetylcarnitine as a new therapeutic approach for peripheral neuropathies with pain. Int J Clin Pharmacol Res (1995) 0.99

Regulation of skeletal muscle AMP deaminase: effects of limited proteolysis on the activity of the rabbit enzyme. FEBS Lett (1979) 0.99

Burden and needs of 487 caregivers of patients in vegetative state and in minimally conscious state: results from a national study. Brain Inj (2012) 0.97

Sleep-related respiratory and haemodynamic changes in Shy-Drager syndrome: a case report. J Neurol (1985) 0.97

The human alpha-1-antitrypsin gene is efficiently expressed from two tissue-specific promotors in transgenic mice. Nucleic Acids Res (1987) 0.96

Increased expression of c-fos, c-jun and LRF-1 is not required for in vivo priming of hepatocytes by the mitogen TCPOBOP. Oncogene (1997) 0.95

Nocturnal frontal lobe epilepsy misdiagnosed as sleep apnea syndrome. Acta Neurol Scand (1998) 0.94

Clinical correlates of brain morphometric features of subjects with low-functioning autistic disorder. J Child Neurol (2000) 0.93

Actuarial analysis of the occurrence of remissions following thymectomy for myasthenia gravis in 400 patients. J Neurol Neurosurg Psychiatry (1991) 0.93

Temporal and tissue-specific expression of the MET ORF driven by the complete transcriptional unit of human A1AT gene in transgenic mice. Gene (1995) 0.93

Applying proteomic technology to clinical virology. Clin Microbiol Infect (2012) 0.93

Isolation and characterization of a murine resident liver stem cell. Cell Death Differ (2007) 0.92

Influence of laboratory homogenization procedures on trace element content of food samples: an ICP-MS study on soft and durum wheat. Food Addit Contam (2001) 0.92

Sleep arousal response to experimental thermal stimulation during sleep in human subjects free of pain and sleep problems. Pain (2000) 0.92

'Nocturnal groaning': just a sound or parasomnia? J Sleep Res (2005) 0.92

Blood lymphocytes are sensitized to branchial plexus nerves in patients with neuralgic amyotrophy. Acta Neurol Scand (1991) 0.92

Skin pathology findings in a cohort of 1500 adult and elderly subjects. Int J Dermatol (1999) 0.91

Tartronates: a new generation of drugs affecting bone metabolism. J Bone Miner Res (1997) 0.91

Disability and quality of life in headache: where we are now and where we are heading. Neurol Sci (2013) 0.90

Physiological hypnic myoclonus. Electroencephalogr Clin Neurophysiol (1988) 0.90

Muscle AMP aminohydrolase. X. Effect of anions on the kinetic and regulatory properties of the rat muscle enzyme. Ital J Biochem (1974) 0.90

Effects of storage on activity and subunit structure of rabbit skeletal-muscle AMP deaminase. Biochem J (1980) 0.90

Arteriolosclerotic leucoencephalopathy in the elderly and its relation to white matter lesions in Binswanger's disease, multi-infarct encephalopathy and Alzheimer's disease. J Neurol Sci (1990) 0.90

Transcranial magnetic stimulation in Alzheimer disease: motor cortex excitability and cognitive severity. Neurosci Lett (2001) 0.90

Muscle AMP aminohydrolase. IV. Purification of rat muscle enzyme. Ital J Biochem (1971) 0.90

Evidence for a common progenitor of epithelial and mesenchymal components of the liver. Cell Death Differ (2013) 0.90

Chromosome abnormalities and epilepsy. Epilepsia (2001) 0.90

Familial cortical tremor, epilepsy, and mental retardation: a distinct clinical entity? Arch Neurol (1998) 0.89

Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients. Dement Geriatr Cogn Disord (2012) 0.89

Muscle AMP aminohydrolase. II. Distribution of AMP aminohydrolase, myokinase and creatine kinase activities in skeletal muscle. Biochim Biophys Acta (1969) 0.89

Specific modification of the GTP binding sites of rat 5'-adenylic acid aminohydrolase by periodate-oxidized GTP. Biochim Biophys Acta (1976) 0.89

Interferon alpha-2a treatment of relapsing-remitting multiple sclerosis: disease activity resumes after stopping treatment. Neurology (1996) 0.89

Association of IL-1 RN*2 allele and methionine synthase 2756 AA genotype with dementia severity of sporadic Alzheimer's disease. J Neurol Neurosurg Psychiatry (2004) 0.88

Association of purified skeletal-muscle AMP deaminase with a histidine-proline-rich-glycoprotein-like molecule. Biochem J (1997) 0.88

Burden of caregivers of patients in Vegetative state and minimally conscious state. Acta Neurol Scand (2012) 0.88

Squamous cell carcinoma and infection in a solitary hepatic cyst. Eur J Gastroenterol Hepatol (1998) 0.88

Isozymes of AMP deaminase in red and white skeletal muscles. FEBS Lett (1975) 0.88

Autonomic function in narcolepsy: power spectrum analysis of heart rate variability. J Neurol (1997) 0.88